Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00280735
Status:
COMPLETED
Last Update Posted:
2017-07-11
First Post:
2006-01-19
Brief Title:
Ph II Adjuvant CarboplatinDocetaxel in Curatively Resected Stage I-IIIA NSCLC
Sponsor:
Organization:
UNC Lineberger Comprehensive Cancer Center